subgroup of
risk)
→
HasProperty
→
higher
| Typicality: | 0.590 |
| Saliency: | 1.000 |
| in each age group | 5 | other |
| among male | 3 | other |
| in clinical trials for epilepsy | 3 | location |
| relative risk → be → higher | 14 |
| relative risk → be → greater | 4 |
| negative | neutral | positive |
| 0.539 | 0.431 | 0.030 |
| Raw frequency | 18 |
| Normalized frequency | 1.000 |
| Modifier score | 0.500 |
| Perplexity | 173.249 |